NCT01223326View on ClinicalTrials.gov

N-acetylcysteine to Reduce Ischemia/Reperfusion Injury in Liver Resection

PHASE4CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

October 31, 2007

Study Completion Date

December 31, 2007

Conditions
HepatectomyReperfusion Injury
Interventions
DRUG

Acetylcysteine (NAC)

NAC 150 mg/Kg; and infusion of 50 mg/kg, from 30 minutes before the ischemia up to 60 minutes later to the reperfusion

DRUG

Saline

Na Cl 0.9% infusion

Trial Locations (1)

31008

Clinica Universidad de Navarra, Pamplona

All Listed Sponsors
lead

Clinica Universidad de Navarra, Universidad de Navarra

OTHER

NCT01223326 - N-acetylcysteine to Reduce Ischemia/Reperfusion Injury in Liver Resection | Biotech Hunter | Biotech Hunter